SCHEMBL25815137

SCHEMBL25815137

CC1COc2cc(C(C)(C)C)ccc2OCC(C(C)O)COc2cc(C(C)(C)C)ccc2OC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
TRPV1 Q8NER1 9/20 0.37
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
AIMP2 Q13155 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 4/20 0.35
LMNA P02545 2/20 0.35
CXCR5 P32302 1/20 0.35
APLNR P35414 1/20 0.35
CCR6 P51684 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
PGR P06401 1/20 0.33
AR P10275 1/20 0.33
GABRA1 P14867 1/20 0.33
MAOA P21397 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23024716 0.87 CYP19A1 (0.46) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL25815131 0.80 CYP19A1 (0.41) CYP19A1TRPV1RAB9AALDH1A1MAPT
SCHEMBL22134628 0.76 CYP19A1 (0.44) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL25814574 0.72 CYP19A1 (0.42) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL20021304 0.71 CYP19A1 (0.43) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL20021313 0.71 CYP19A1 (0.43) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL22134660 0.71 TRPV1 (0.37) CYP19A1TRPV1RAB9ANPC1MAPT
SCHEMBL21101055 0.71 ALDH1A1 (0.47) CYP19A1RAB9ANPC1AIMP2ALDH1A1
SCHEMBL25815539 0.70 CYP19A1 (0.34) CYP19A1TRPV1RAB9ANPC1AIMP2
SCHEMBL22134641 0.70 TRPV1 (0.43) CYP19A1TRPV1RAB9ANPC1AIMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS ORCA HOLDINGS, LLC 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS LCLAT1, LCT, IGF2R CYP19A1 4811/4885TRPV1 434/4885RAB9A 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.